Status of Drug Discovery in Wetlands Through a Lens of Bioprospecting for New Antimicrobials Being Produced by Microorganisms

Bojana Stekovic, Karl Anderson, Delainey Lancaster, Evelyn Stuck, Tsebaot Getachew, Venugopal Mukku, Brian J. Dingmann

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of Review: The current review focuses on opportunities for new areas and new methods to isolate microorganisms from soil that could lead to new antimicrobial compounds. Recent Findings: Ongoing investigation of wetland microbial communities is vital for identifying novel antibiotics to combat the escalating threat of AMR. Exploring uncultured bacteria in soil has also led to promising compounds like teixobactin, which is effective against drug-resistant bacteria. Summary: Bioprospecting for new antimicrobials in wetland environments that focus on previously unculturable bacteria is an emerging field of study. The need for new antimicrobials demands innovative approaches to discovery, such as the Tiny Earth project, and a collaborative focus, such as the One Health Initiative.

Original languageEnglish (US)
Pages (from-to)214-221
Number of pages8
JournalCurrent Clinical Microbiology Reports
Volume10
Issue number4
DOIs
StatePublished - Dec 2023

Bibliographical note

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Keywords

  • Antibiotic resistance
  • Bioprospecting
  • One Health
  • Tiny Earth project
  • Unculturable bacteria
  • Wetlands

Fingerprint

Dive into the research topics of 'Status of Drug Discovery in Wetlands Through a Lens of Bioprospecting for New Antimicrobials Being Produced by Microorganisms'. Together they form a unique fingerprint.

Cite this